Astellas Pharmas digitala produktmöte XOSPATATM

Astellas Pharma Nordic *), will process as data controller the personal information stated above in order to document your attendance at this event. We respect your right to privacy. You can read more about how we use your personal information, and how you can exercise your privacy rights, in our Event Privacy Notice

*) For the purpose of this attendee list, “Astellas Pharma Nordic” shall mean Astellas Pharma a/s (Denmark), Astellas Pharma AB (Sweden), Astellas Pharma (Norway) and Astellas Pharma A/S, filial in Finland (Finland).


Do you want to receive healthcare, medical and scientific-related materials from Astellas Pharma in the future?

IMPORTANT: Your consent is voluntary and you can withdraw it at any time by clicking the “unsubscribe” link in any email communication you receive from Astellas going forward, or alternatively by sending an email to privacy@astellas.com

Astellas is committed to protecting your personal information and will only use it in accordance with the applicable data privacy law and our Astellas Privacy Notice. For further information on how we process and protect your personal information and how you may exercise your data protection rights, please refer to our Privacy Notice at https://policy.astellas.dk/en-general-privacy-notice/

If you have any questions or concerns, please contact us at privacy@astellas.com.

*) For the purpose of this consent, “Astellas Pharma Nordic” shall mean Astellas Pharma a/s (Denmark), Astellas Pharma AB (Sweden), Astellas Pharma (Norway) and Astellas Pharma A/S, filial in Finland (Finland).

** Astellas complies with the current Lif agreements with the Danish Regions and will not send any invitations directly to any hospital-employed HCPs where not allowed.


Genom att trycka på ’Anmäl’ godkänner du att vi skickar dig mejl som rör detta webbinarium. Några dagar innan mötet kommer ett mejl med länken som du ska använda för att ansluta till webbinariet.


    
     
   

XOS_2021_0021_SE 04.2021